Loading...
BioLife Solutions, Inc.
BLFS•NASDAQ
Healthcare
Medical - Instruments & Supplies
$22.58
$0.32(1.44%)
BioLife Solutions, Inc. (BLFS) Financial Performance & Income Statement Overview
Review BioLife Solutions, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-42.59%
↓ 42.59%
Operating Income Growth
89.93%
↑ 89.93%
Net Income Growth
69.61%
↑ 69.61%
Operating Cash Flow Growth
167.46%
↑ 167.46%
Operating Margin
-5.27%
↓ 5.27%
Gross Margin
76.50%
↑ 76.50%
Net Profit Margin
-13.11%
↓ 13.11%
ROE
-3.09%
↓ 3.09%
ROIC
-1.14%
↓ 1.14%
BioLife Solutions, Inc. (BLFS) Income Statement & Financial Overview
Review BioLife Solutions, Inc.'s (BLFS) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | -$3.42M | $30.57M | $28.33M | $31.73M |
| Cost of Revenue | -$11.70M | $8.77M | $13.44M | $20.08M |
| Gross Profit | $8.27M | $21.81M | $14.89M | $11.65M |
| Gross Profit Ratio | -$2.42 | $0.71 | $0.53 | $0.37 |
| R&D Expenses | $1.08M | $2.05M | $2.38M | $3.53M |
| SG&A Expenses | $5.80M | $14.89M | $14.40M | $18.004M |
| Operating Expenses | $6.88M | $23.36M | $22.51M | $21.54M |
| Total Costs & Expenses | -$4.81M | $32.13M | $31.12M | $41.62M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $267000.00 | $361000.00 | $207000.00 |
| Depreciation & Amortization | $1.70M | $2.32M | $2.36M | $2.28M |
| EBITDA | $6.75M | $853000.00 | -$4.38M | -$7.61M |
| EBITDA Ratio | -$1.97 | $0.03 | -$0.15 | -$0.24 |
| Operating Income | $1.39M | -$1.56M | -$2.79M | -$9.89M |
| Operating Income Ratio | -$0.40 | -$0.05 | -$0.10 | -$0.31 |
| Other Income/Expenses (Net) | $157000.00 | -$172000.00 | -$4.35M | $38000.00 |
| Income Before Tax | $1.54M | -$1.73M | -$7.15M | -$10.09M |
| Income Before Tax Ratio | -$0.45 | -$0.06 | -$0.25 | -$0.32 |
| Income Tax Expense | -$131000.00 | -$28000.00 | $0.00 | $131000.00 |
| Net Income | $12.46M | -$1.70M | -$20.72M | -$10.22M |
| Net Income Ratio | -$3.64 | -$0.06 | -$0.73 | -$0.32 |
| EPS | $0.27 | -$0.04 | -$0.45 | -$0.22 |
| Diluted EPS | $0.27 | -$0.04 | -$0.45 | -$0.22 |
| Weighted Avg Shares Outstanding | $46.65M | $46.18M | $46.004M | $45.43M |
| Weighted Avg Shares Outstanding (Diluted) | $48.03M | $46.18M | $46.004M | $45.43M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan